No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“No significant beneficial effect of Huperzine A on the improvement of cognitive function measured by MMSE for VaD (WMD 2.40; 95% CI -4.78 to 9.58) was observed.”
- Study
- RCT
- Effect
- 2.4 mean difference, 95% CI −4.78 to 9.58
- Population
- patients with vascular dementia; the review's single included trial
Study record
- Design
- meta-analysis / randomised controlled trial / systematic review, not pooled
- Species
- human
- Population
- patients with vascular dementia (VaD)
- Participants
- 14
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 2